Skip to main content
SpringerLink
Log in

Role of reactive oxygen species in pathogenesis of nephrotic syndrome

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Nephrotic syndrome is the common chronic disorder characterized by alteration of permeability of the glomerular capillary wall, resulting in its inability to restrict the urinary loss of proteins. Nephrotic syndrome is characterized by heavy proteinuria, hypoalbuminemia, hyperlipidemia associated with peripheral edema. The molecular basis of glomerular permselectivity remains largely unknown. In recent years it has been proposed that Nephrotic syndrome is a consequence of an imbalance between oxidant and antioxidant activity. The present study was aimed to test that the reactive oxygen species are the mediators of excessive protein permeability and other complications of Nephrotic syndrome. For this 30 adults with Nephrotic syndrome were studied. The control group comprised 30 healthy adults matched for age. Serum levels of lipid peroxides, nitric oxide (NO⊙), α- tocopherol, ascorbic acid, erythrocyte superoxide dismutase activity, serum albumin, uric acid, cholesterol and plasma total antioxidant capacity were measured. Student’s ‘t’ test was applied for statistical analysis. There was a significant increase in lipid peroxide (1.58 ± 0.42 in controls, 3.64 ±1.3 in patients) (P<0.001) levels in study group as compared with controls. α-tocopherol (12.95 ± 1.04 in controls, 9.93 ± 1.43 in patients) (P<0.001), erythrocyte SOD activity(1.88 ± 0.9 in controls 1.07 ± 0.5 in patients) (P=0.01), serum albumin(4.06 ± 0.50 in controls, 3.04 ± 0.11 in patients) (P<0.001), and plasma total antioxidant capacity (847.33 ± 126.83 in controls, 684.00±102.94 in patients) (P<0.001) were significantly decreased. There was non-significant increase in uric acid (P>0.05), a non-significant decrease in NO⊙ (38.48 ± 15.47 in controls 37.47 ± 14.27 in patients) (P>0.05) and ascorbic acid levels ascorbic acid,( 0.95 ± 0.31in controls 0.79 ± 0.30 in patients) (P>0.05) in study group as compared with controls. Imbalance between oxidants and antioxidants may contribute to pathogenesis of proteinuria and related complications in nephrotic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zachwieja J, Bobkowski W, Zaniew M, Dobrowolska-Zachwieja A, Lewandowska-Stachowiak M, Siwinska A. Apoptosis and antioxidant defense in the nephrotic syndrome. Pediatr Nephrol 2003; 18: 1116–1121.

    Article  PubMed  Google Scholar 

  2. McBryde KD, Kershaw DB, Smoyer WE. Pediatric steroid-resistant nephrotic syndrome. Curr Probl Pediatr 2001; 31: 275–307.

    Article  Google Scholar 

  3. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica Chemical Acta 1978; 90: 37–43.

    Article  CAS  Google Scholar 

  4. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by kinetic cadmium — reduction method. Clin Chem 1990;36(8): 1440–1143

    CAS  PubMed  Google Scholar 

  5. Doumas (Modified Spencer and Price 1977). Determination of serum albumin using Bromocresol Green. Practical Clinical Biochemistry; Heinemann professional publishing 5th edition; 1980: 553–554.

  6. Das K. A modified spectrophotometric assay of superoxide dismutase using nitrate formation by superoxide radicals. Ind J Biochem Biophys 2000; 57: 201–204.

    Google Scholar 

  7. Baker, Frank. Determination of Serum tocopherol by colorimetric method. In Varley’s practical Clinical Biochemistry, 6th edition: Heinmann Professional Publishing 1988; 902.

  8. Caraway WT. Carbohydrates in Tietz NW (Ed): Fundamentals of clinical chemistry. W B Saunder Company 173–176.

  9. Iris FF, Benzie, Strain JJ. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Analytical Biochem 1996; 239 (1): 70–76.

    Article  Google Scholar 

  10. Dogra G, Ward N, Croft KD, Mori TA, Barrett PHR, Herrmann SE, et al. Oxidant stress in nephrotic syndrome: comparison of F2-isoprostanes and plasma antioxidant potential. Nephrol Dial Transplant 2001; 16: 1626–1630.

    Article  CAS  PubMed  Google Scholar 

  11. Kinra S, Rath B, Kabi BC. Indirect quantification of lipid per oxidation in steroid responsive nephrotic syndrome. Arch Dist Child 2000; 82: 76–78.

    Article  CAS  Google Scholar 

  12. Raasts CJI, Bakker MAH, Born JVD, Berden JHM. Hydroxyl radicals depolymerize glomerular heparan sulphates in vitro and in experimental nephrotic syndrome. J Biol Chem 1997; 272 (42): 26734–36741.

    Article  Google Scholar 

  13. Raats CJI, Born JVD, Berden JHM. Glomerular heparin sulfates alterations: Mechanism and relevance for proteinuria. Kidney Int 2000; 57: 385–400.

    Article  CAS  PubMed  Google Scholar 

  14. Isaacs BR, Pawar B, Sajiv CT, Calton N, Isaacs R. Barraquer — Simons Disease-A Rare cause of proteinuria. Ind J Nephrol 1997; 7(1): 31–32.

    Google Scholar 

  15. Bryde KDM, Kershaw DB, Smoyer WE. Pediatric steroid-resistant nephrotic syndrome. Curr Probl Pediatr 2001; 31: 275–307.

    Google Scholar 

  16. Wever R, Boer P, Hampering M, Stores E, Gerhard M, Versluis JKK, et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 1999; 19: 1168–1172.

    CAS  PubMed  Google Scholar 

  17. Ni Z, Vaziri ND. Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria. Biochim Biophys Acta 2003; 1638(2): 129–137.

    CAS  PubMed  Google Scholar 

  18. Duran P, Datta PK, Pan C, Blumberg JB, Sharma M, Lianos EA. Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein. J Pharmacol Experimental Therapeutics 2006; 316 (3): 1249–1254.

    Google Scholar 

  19. Goldstone A, Rastegar R, Shariftabrizi A, Payabvash SKSM, Salmasi AH, Dehpour AR, et al. Paradoxical dose and time- dependent regulation of superoxide dismutase and antioxidant capacity by vitamin E in rat. Clin Chim Acta 2006; 265: 153–159.

    Google Scholar 

  20. Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: Their regulation and function. Kidney Int 1994; 45: 1–9.

    Article  CAS  PubMed  Google Scholar 

  21. Tian J, Chen JH, Li Q, He Q, Lin WQ. Lipid peroxidation in IgA nephropathy and the effect of lipo — prostaglandin E1. J Nephrol 2005; 18: 243–248.

    CAS  PubMed  Google Scholar 

  22. Young IS, Woodside JV. Antioxidants in health and disease. J. Clin Petrol 2001; 54: 176–186.

    CAS  Google Scholar 

  23. Padayatti SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, et al. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J Am College of Nutr 2003; 22 (1): 18–35.

    Google Scholar 

  24. Rajbala A, Sane AS, Cope J, Mishra VV, Trivedi HL. Oxidative stress status in children with nephrotic syndrome. Panminerva Med 1997;39(3): 165–168

    CAS  PubMed  Google Scholar 

  25. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in human aging and cancer: A hypothesis. Proc Natl Acad Sci USA 1981; 78 (11): 6858–6862.

    Article  CAS  PubMed  Google Scholar 

  26. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999; 13: 233–244.

    CAS  PubMed  Google Scholar 

  27. Zachwieja J, Bobkdwski Dobrowolska-Zachwieja A, Zaniew M, Maciejewsk J. Decreased antioxidant activity in hypercholesterolemic children with nephrotic syndrome. Med Sci Monit 2003; 9 (6): CR 287–CR 291.

    Google Scholar 

  28. Vaziri ND, Liang K, Parks JS. Acquired lecithin — cholesterol acyltransferase deficiency in nephrotic syndrome. Am J Physiol Renal Physiol 2001; 49: F 823–F 828.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, K. B. N. Institute of Medical Sciences, Gulbarga, 585104, Karnataka, India

    Santoshi R. Ghodake, K. Shaikh & A. V. Katta

  2. Dr. V M Govt. Medical College, Solapur, Maharashtra, India

    A. N. Suryakar & R. D. Ankush

Authors
  1. Santoshi R. Ghodake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. N. Suryakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. D. Ankush
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Shaikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. V. Katta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Santoshi R. Ghodake.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghodake, S.R., Suryakar, A.N., Ankush, R.D. et al. Role of reactive oxygen species in pathogenesis of nephrotic syndrome. Indian J Clin Biochem 25, 82–85 (2010). https://doi.org/10.1007/s12291-010-0017-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-010-0017-y

Key Words

Search

Navigation